Aerami Therapeutics Holdings, Inc. — Form D/A

Aerami Therapeutics Holdings, Inc. of Durham, NC, a company, filed a Form D amendment with the SEC on 2017-06-26. The offering totals $5.0M, of which $3.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (45)

Showing 25 of 45 people.

NameRoleLocation
Gary C BurgessExecutive OfficerDurham, NC
Anne C WhitakerDirectorDurham, NC
Anne C WhitakerExecutive OfficerDurham, NC
John S PattonDirectorDurham, NC
Steven C ThorntonDirectorDurham, NC
William Patrick WelchDirectorDurham, NC
Joshua S ZielExecutive OfficerDurham, NC
Darlene C Deptula-HicksDirectorDurham, NC
Darlene C Deptula-HicksExecutive OfficerDurham, NC
BILL K WELCHDirectorDEERFIELD, IL
STEVEN S THORNTONDirectorDEERFIELD, IL
STEVEN S THORNTONExecutive OfficerDEERFIELD, IL
DARLENE K DEPTULA-HICKSDirectorDEERFIELD, IL
BARRY K DEUTSCHExecutive OfficerDEERFIELD, IL
LISA K YANEZExecutive OfficerDEERFIELD, IL
TIMM JEFFREY CROWDERExecutive OfficerDURHAM, NC
BILL S WELCHDirectorDURHAM, NC
ADAM S STERNDirectorDURHAM, NC
K JEFFREY BELLExecutive OfficerDURHAM, NC
STEVE S THORNTONDirectorDURHAM, NC
STEVE S THORNTONExecutive OfficerDURHAM, NC
DARLENE JEFFREY DEPTULA-HICKSDirectorDURHAM, NC
KENNETH B LEE, JR.DirectorDURHAM, NC
TIMM J CROWDERExecutive OfficerDURHAM, NC
BENJAMIN S WOLINDirectorDURHAM, NC

Other filings by this issuer (12)

FiledFormOfferingSold
2023-11-22D$20.0M$1.0M
2022-12-16D$20.0M$5.4M
2021-11-04D/A$22.3M$22.3M
2021-09-23D$20.0M$2.2M
2020-06-17D$15.0M$4.6M
2019-06-11D/A$59.2M$21.0M
2019-06-10D$59.2M$21.0M
2018-01-11D/A$36.7M$19.0M
2017-12-18D$40.0M$14.7M
2017-04-26D$5.0M$838K
2016-08-04D$23.0M$625K
2015-10-02D$40.0M$10.1M

More